Back to Atlas
BSemi-durableNootropic/stimulant caution
CMP-0176
Regional/Research
Bromantane
Dopaminergic / Eugeroic
Motivation, fatigue resistance and dopaminergic adaptation
Reading this compound Reference only
Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.
Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.
Mechanism & Use
- Compound type
- Small molecule
- Primary mechanism
- Dopamine synthesis and stimulant-adaptogenic mechanisms
- Primary market use
- Fatigue/performance
Pharmacology
- Molecular weight (Da)
- 306.2
- Oral bioavailability
- High
- Half-life
- ~11 h
- Route tags
- Oral
- Evidence level
- Human/Regional
- Clinical status
- Regional/Research
- Value-for-money score
- 7 / 10
Reported protocol signal
No popular protocol verified yet; keep as reference compound until protocol signal is added.
For orientation only. See disclaimer — always consult a licensed clinician before use.
Notes
Often placed in durable functional adaptation rather than acute stimulant